Tideman Philip A, Tirimacco Rosy, St John Andrew, Roberts Gregory W
Australian Point of Care Practitioners Network ; Integrated Cardiovascular Clinical Network, Country Health South Australia, Adelaide.
Australian Point of Care Practitioners Network.
Aust Prescr. 2015 Apr;38(2):44-8. doi: 10.18773/austprescr.2015.016. Epub 2015 Apr 1.
Long-term treatment with warfarin is recommended for patients with atrial fibrillation at risk of stroke and those with recurrent venous thrombosis or prosthetic heart valves. Patient education before commencing warfarin - regarding signs and symptoms of bleeding, the impact of diet, potential drug interactions and the actions to take if a dose is missed - is pivotal to successful use. Scoring systems such as the CHADS2 score are used to determine if patients with atrial fibrillation are suitable for warfarin treatment. To rapidly achieve stable anticoagulation, use an age-adjusted protocol for starting warfarin. Regular monitoring of the anticoagulant effect is required. Evidence suggests that patients who self-monitor using point-of-care testing have better outcomes than other patients.
对于有中风风险的房颤患者、复发性静脉血栓形成患者或人工心脏瓣膜患者,建议长期使用华法林治疗。在开始使用华法林之前对患者进行教育——关于出血的体征和症状、饮食的影响、潜在的药物相互作用以及漏服一剂时应采取的措施——对于成功用药至关重要。诸如CHADS2评分等评分系统用于确定房颤患者是否适合华法林治疗。为了迅速实现稳定的抗凝,使用年龄调整方案启动华法林治疗。需要定期监测抗凝效果。有证据表明,使用即时检验进行自我监测的患者比其他患者有更好的治疗效果。